already tried cocktail being used against a secondary if AIDS-related condition. Finally, the cocktail idea is being somewhat refined in another development related directly to AZT and 3TC, in which the Glaxo Wellcome pharmaceutical company is working already to combine the two drugs into a single pill (Tanouye, 1996).
The Current Medical Research and Treatment Modalities
Beyond question, much medical research is under way with combination drug therapy, but reported here are those findings both announced at the 11th International Conference on AIDS in Vancouver and then re-reported in the popular press. [Sternberg (1996, p. 21) says that Science News revealed "the first human trials" with PIs singly or in combination in its March 23, 1996 edition.]
The medical researcher who managed to garner the broadest media attention and star potential from the Vancouver conference was clearly Dr. David Ho, a virologist and director of the Aaron Diamond AIDS Research Center in New York (Waldholz, 1996; Gorman(a)). Ho reported results from
...